Never miss a story

Get subscribed to our newsletter


×
Study gives us hope for repurposing common drugs for young cancer patients desperately requiring better treatment options. Pixabay

In a major study, researchers have found that a commonly prescribed anti-depressant may halt the growth of a type of cancer known as childhood sarcoma.

In mice and laboratory cell experiments, the study, published in the journal Cancer Research, the research team ignited hopes of novel treatment strategies against this disease.


“This study gives us hope for repurposing common drugs for young cancer patients desperately requiring better treatment options,” said study lead author Caitrín Crudden from Karolinska Institutet in Sweden.

Follow NewsGram on Twitter to stay updated about the World news.

The study examined commonalities between two large groups of cell surface receptors, the so-called G protein-coupled receptors (GPCRs) and the receptor tyrosine kinases (RTKs).

GPCRs are targeted by more than half of all developed drugs to treat conditions such as allergies, asthma, depression, anxiety, and hypertension, but have so far not been widely used to treat cancers.

RTKs, on the other hand, are targeted by drugs against cancers, such as breast and colon cancers, due to their implication in a variety of cellular abnormalities.

Follow NewsGram on Instagram to keep yourself updated.

One receptor in the RTK family that plays a key role in many cancers, including childhood sarcoma, is the insulin-like growth factor receptor (IGF1R). However, previous attempts to develop anti-cancer drugs against this receptor have failed.


This strategy opens new possibilities of repurposing well-tolerated drugs to silence this tumor-driving receptor and thereby halt cancer growth. Pixabay

In this study, the researchers scrutinized the IGF1R and found that it shares a signaling module with the GPCRs, meaning it may be possible to affect its function through drugs targeting the GPCRs.

Want to read more in Hindi? Checkout: हरियाणा के सभी शहरों में लगेंगे सीसीटीवी कैमरे : स्थानीय निकाय मंत्री अनिल विज

This strategy opens new possibilities of repurposing well-tolerated drugs to silence this tumor-driving receptor and thereby halt cancer growth.

To test their hypothesis, the researchers treated childhood sarcoma cells and mouse models with Paroxetine, an anti-depressant drug that impairs a serotonin reuptake receptor that is part of the GPCR family.

They found that this drug significantly decreased the number of IGF1R receptors on the malignant cells and thereby suppressed the growth of the tumor.

ALSO READ: Very Few Consumers Think Their Food is Safe

The researchers also uncovered the molecular mechanism behind this cross-targeting.

“We have developed a novel strategy to control the activity of these tumor-driving receptors by striking the GPCRs,” said study author Leonard Girnita from Karolinska Institutet. (IANS)


Popular

Unsplash

When you're pregnant, the immune system is seeing the placenta for the first time in decades.

The US researchers have discovered a class of immune cells that plays a role in miscarriage, which affects about a quarter of pregnancies.

Researchers at the University of California-San Francisco found that the recently discovered subset of cells known as extrathymic Aire-expressing cells in the immune system may prevent the mother's immune system from attacking the placenta and fetus.

The researchers showed that pregnant mice who did not have this subset of cells were twice as likely to miscarry, and in many of these pregnancies fetal growth was severely restricted.

ALSO READ: Can You Drink Coffee While You're Pregnant?

"When you're pregnant, the immune system is seeing the placenta for the first time in decades -- not since the mother made a placenta when she herself was a fetus," said Eva Gillis-Buck, from UCSF.

"Our research suggests that this subset of immune cells is carrying out a sort of 'secondary education' -- sometimes many years after the better-known population of the educator cells have carried out the primary education in the thymus -- teaching T cells not to attack the fetus, the placenta and other tissues involved in pregnancy," she added. The findings are published in the journal Science Immunology.

Keep Reading Show less
Unsplash

It's not surprising that over half of those surveyed feel more comfortable using emojis than talking on the phone or in person.

The tiny emojis being shared on billions of devices worldwide can play a major role in digital communication, with most people saying that emoji compels them to feel more empathy towards others, according to an Adobe report.

Adobe's global emoji study found that emoji even helps people overcome language barriers and form connections that would otherwise be difficult to do.

"We were surprised and delighted by the discoveries made in the survey, most notably how enthusiastic respondents were for emoji as a means to express themselves," the company said in a statement.

ALSO READ: Emoji- A Choice for Interracial Couple

Emojis sometimes get criticized for being overly saccharine, but this sweetness is key when it comes to diffusing some of the heaviness of online communication.

"Many of the emoji are focused on positive emotions, so it's easy to insert them into our conversations and lighten the mood," the Adobe study said.

Keep Reading Show less
Wikimedia Commons

Jeff Bezos at the ENCORE awards.

Following the grand Richard Branson show where he carried Andhra Pradesh-born Sirisha Bandla and fellow space travelers on his shoulders after successfully flying to the edge of space, it is time for Amazon Founder Jeff Bezos to applaud Sanjal Gavande, one of the key engineers who designed the New Shephard rocket set to take Bezos and the crew to space on July 20.

Billionaire Bezos is set to fly to the edge of space aboard what is touted as the world's first unpiloted suborbital flight. Born in Kalyan, Maharashtra, Gavande is a systems engineer at Blue Origin who always dreamt of designing aerospace rockets.

ALSO READ: Jeff Bezos Used To Review Products On Amazon

After completing Bachelor's in mechanical engineering from the University of Mumbai, she flew to the US in 2011 to pursue a Master's in mechanical engineering from the Michigan Technological University. She also applied for an engineering job at the US space agency NASA but finally landed her dream job at Blue Origin

Keep reading... Show less